After decades of research and millions in R & D funding, we might be seeing some fruit from the labors.
The Food and Drug Administration has approved a pill that aims to increase a woman's desire for sex — a controversial decision made only after an extended lobbying campaign by the drug's makers.
The pill's called flibanserin and will be marketed under the brand name Addyi. The FDA is asking its maker, Sprout Pharmaceuticals, to specially train doctors and pharmacists who dispense it and to keep track of any problems with women taking the drug. Only trained physicians will be allowed to write prescriptions for the pill.
Sprout, which bought rights to the drug when pharma giant Boehringer Ingelheim dumped it, helped wage a public relations campaign called "Even the Score." It claimed that while men have many different sexual dysfunction drugs to choose from, including Viagra and Cialis, women have none.
Not sure if I'd call it the answer to all of our problems just quite yet though.
Studies show that on average Addyi increased the number of so-called satisfying sexual events by half to one additional event per month over placebo.
This may all be a moot point as football season officially kicks off in less than a month but there's always hope for future offseasons...